Analysts Downgrade Merck and Pfizer on Patent Cliff, Exclusivity Concerns – IPWatchdog.com
Analysts Downgrade Merck and Pfizer on Patent Cliff, Exclusivity Concerns IPWatchdog.com Last month, business news outlets were reporting that stock prices for pharmaceutical firms Pfizer and Merck took a tumble after financial analysts downgraded …